Simon Moroney, D.Phil.

Board member since 2020 | Vice-Chair since March 4, 2022

Nationality: German/New Zealander | Year of birth: 1959

As co-founder and CEO of MorphoSys AG, Simon Moroney played a central role in establishing the company as a force in the field of therapeutic antibodies, with one of the broadest pipelines of drug candidates in the industry. Mr. Moroney holds both a doctorate and a Master’s degree in chemistry.

Professional experience

  • Co-founder and CEO, MorphoSys AG, Germany (1992–2019)
  • Research associate, Department of Pharmacology, University of Cambridge, UK (1991–1992)
  • Assistant professor, Department of Chemistry, University of British Columbia, Canada (1989–1990)


  • Chair of the board of directors and the remuneration and nomination committee, Biotalys NV, Belgium


  • Doctorate in chemistry, University of Oxford, UK
  • Master’s degree in chemistry, University of Waikato, New Zealand

Key skills

  • Medicine/healthcare/R&D
  • Environmental, social and governance (ESG)
  • Leadership/management
  • Law/regulatory/risk management